Adverse Event Reporting

According to the relevant laws and regulations, marketing authorization holders are obliged to carry out the post-marketing surveillance of drugs. This page will collect information related to your unsolicited feedback to the extent permitted.

If the information you provide relates to a adverse event involving Akeso’s products, the relevant patient information and data will be disclosed to Akeso’s pharmacovigilance department in accordance with the applicable laws and regulations, and the relevant personnel may follow up with you on the safety event. The information will be input into Akeso’s pharmacovigilance database and reported to the relevant regulatory departments in accordance with the applicable laws and regulations. Items marked with * are required. Please fill in the information accurately.

Note: The information marked with * is a required option, please fill in accurately.

*Choose your identity:
Adverse Event Reporting

According to the relevant laws and regulations, marketing authorization holders are obliged to carry out the post-marketing surveillance of drugs. This page will collect information related to your unsolicited feedback to the extent permitted. If the information you provide relates to a adverse event involving Akeso’s products, the relevant patient information and data will be disclosed to Akeso’s pharmacovigilance department in accordance with the applicable laws and regulations, and the relevant personnel may follow up with you on the safety event. The information will be input into Akeso’s pharmacovigilance database and reported to the relevant regulatory departments in accordance with the applicable laws and regulations. Items marked with * are required. Please fill in the information accurately.

  • Physician Information
  • Reporter Information
  • Patient Information
  • Product Information
  • Adverse Event
  • Other Information

  • *Does the attending physician want to be followed up?

    *Physician initials

    *Employer

    *Contact (phone or email)

    Previous
    Next Step

  • *Your initials

    *Nationality

    *Contact Information (Tel. or Email)

    *Employer

    *Do you want to be followed up?​

    Previous
    Next Step

  • *Patient initials

    *Date of Birth

    *Gender

    Previous
    Next Step

  • *Product Name

    *Lot Number (see drug packaging)​

    Tip: usually 15 characters, e.g. AA101P202205001

    Treatment Dates/Therapy Dates

    Single dose

    Dose taken each time

    Administration frequency

    e.g. once every 3 weeks

    Reason(s) for Medication​

    Previous
    Next Step

  • *Event name

    *Country/region where event occurred

    Event date

    *Is the event serious?

    *Event Outcome

    *In your opinion, the event and Akeso’s product are:

    Event end date

    Previous
    Next Step

  • * Other Information (please describe the occurrence and development of the adverse event; symptoms and signs; process of diagnosis and treatment; relevant laboratory tests; imaging findings, etc.)

    Click to get the verification code.
    Previous
    Confirm Submission

According to the relevant laws and regulations, marketing authorization holders are obliged to carry out the post-marketing surveillance of drugs. This page will collect information related to your unsolicited feedback to the extent permitted. If the information you provide relates to a adverse event involving Akeso’s products, the relevant patient information and data will be disclosed to Akeso’s pharmacovigilance department in accordance with the applicable laws and regulations, and the relevant personnel may follow up with you on the safety event. The information will be input into Akeso’s pharmacovigilance database and reported to the relevant regulatory departments in accordance with the applicable laws and regulations. Please fill in the information accurately.

Submitting